840 related articles for article (PubMed ID: 22836914)
1. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
[TBL] [Abstract][Full Text] [Related]
2. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
[TBL] [Abstract][Full Text] [Related]
3. Informed choice vs. no choice in colorectal cancer screening tests: a prospective cohort study in real-life screening practice.
Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SC; Ng SS; Sung JJ
Am J Gastroenterol; 2014 Jul; 109(7):1072-9. PubMed ID: 24935273
[TBL] [Abstract][Full Text] [Related]
4. Physician counseling for colorectal cancer screening: impact on patient attitudes, beliefs, and behavior.
Fenton JJ; Jerant AF; von Friederichs-Fitzwater MM; Tancredi DJ; Franks P
J Am Board Fam Med; 2011; 24(6):673-81. PubMed ID: 22086810
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer screening among Mexican Americans at a community clinic.
Yepes-Rios M; Reimann JO; Talavera AC; Ruiz de Esparza A; Talavera GA
Am J Prev Med; 2006 Mar; 30(3):204-10. PubMed ID: 16476635
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
[TBL] [Abstract][Full Text] [Related]
8. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
[TBL] [Abstract][Full Text] [Related]
9. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer screening among Latinos from U.S. cities along the Texas-Mexico border.
Fernandez ME; Wippold R; Torres-Vigil I; Byrd T; Freeberg D; Bains Y; Guajardo J; Coughlin SS; Vernon SW
Cancer Causes Control; 2008 Mar; 19(2):195-206. PubMed ID: 18038186
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening attitudes and practices preferences for decision making.
Messina CR; Lane DS; Grimson R
Am J Prev Med; 2005 Jun; 28(5):439-46. PubMed ID: 15894147
[TBL] [Abstract][Full Text] [Related]
12. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
13. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
[TBL] [Abstract][Full Text] [Related]
14. Tailored navigation in colorectal cancer screening.
Myers RE; Hyslop T; Sifri R; Bittner-Fagan H; Katurakes NC; Cocroft J; Dicarlo M; Wolf T
Med Care; 2008 Sep; 46(9 Suppl 1):S123-31. PubMed ID: 18725824
[TBL] [Abstract][Full Text] [Related]
15. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening: physician attitudes and practices.
Taylor ML; Anderson R
WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
[TBL] [Abstract][Full Text] [Related]
17. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
18. An intervention to change the approach to colorectal cancer screening in primary care.
Spruce LR; Sanford JT
J Am Acad Nurse Pract; 2012 Apr; 24(4):167-74. PubMed ID: 22486831
[TBL] [Abstract][Full Text] [Related]
19. Equity and practice issues in colorectal cancer screening: Mixed-methods study.
Buchman S; Rozmovits L; Glazier RH
Can Fam Physician; 2016 Apr; 62(4):e186-93. PubMed ID: 27618142
[TBL] [Abstract][Full Text] [Related]
20. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]